{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:10:52Z","timestamp":1770505852566,"version":"3.49.0"},"reference-count":63,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2004,11,10]],"date-time":"2004-11-10T00:00:00Z","timestamp":1100044800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Psychiatr Scand"],"published-print":{"date-parts":[[2005,3]]},"abstract":"<jats:p><jats:bold>Objective:\u2002<\/jats:bold> The European Schizophrenia Out\u2010patient Health Outcomes study is an observational study investigating treatment in schizophrenia. We report treatment\u2010emergent adverse events during the first 6\u2003months of treatment.<\/jats:p><jats:p><jats:bold>Method:\u2002<\/jats:bold> The rate of extrapyramidal symptoms (EPS), anticholinergic use, weight gain and sexual related dysfunctions were assessed in 8400 out\u2010patients.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> Patients typical antipsychotics and risperidone experienced significantly more EPS and anticholinergic use than patients in the clozapine, olanzapine, and quetiapine cohorts. Patients treated with amisulpride, typical antipsychotics and risperidone were significantly more likely to have sexual related dysfunctions and\/or amenorrhea. Increases in weight and body mass index occurred in all cohorts, but were significantly greater in the olanzapine and clozapine cohorts.<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> Patients treated with olanzapine, quetiapine and clozapine had better tolerability outcomes regarding EPS and sexual related dysfunctions compared with patients receiving risperidone, amisulpride and typicals. Patients treated with olanzapine and clozapine had higher weight increases than patients treated with risperidone, quetiapine and typicals.<\/jats:p>","DOI":"10.1111\/j.1600-0447.2004.00451.x","type":"journal-article","created":{"date-parts":[[2005,2,8]],"date-time":"2005-02-08T13:57:24Z","timestamp":1107871044000},"page":"232-243","source":"Crossref","is-referenced-by-count":57,"title":["Olanzapine vs. other antipsychotics in actual out\u2010patient settings: six months tolerability results from the European Schizophrenia Out\u2010patient Health Outcomes study"],"prefix":"10.1111","volume":"111","author":[{"given":"M.","family":"Lambert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. M.","family":"Haro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Novick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. T.","family":"Edgell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ratcliffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Naber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2004,11,10]]},"reference":[{"key":"e_1_2_24_2_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1994.tb05826.x"},{"key":"e_1_2_24_3_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004850-199501005-00005"},{"key":"e_1_2_24_4_2","doi-asserted-by":"publisher","DOI":"10.3109\/10401230209149099"},{"key":"e_1_2_24_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(98)00105-4"},{"key":"e_1_2_24_6_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.2.180"},{"issue":"4","key":"e_1_2_24_7_2","first-page":"12","article-title":"Movement disorders associated with atypical antipsychotic drugs","volume":"63","author":"Caroff SN","year":"2002","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_24_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00111-7"},{"key":"e_1_2_24_9_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216070-00003"},{"key":"e_1_2_24_10_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ps.54.4.565"},{"key":"e_1_2_24_11_2","first-page":"181","volume-title":"Pharmacopsychiatry","author":"Lambert M","year":"2003"},{"key":"e_1_2_24_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1999.tb10908.x"},{"key":"e_1_2_24_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0163-8343(00)00081-5"},{"issue":"23","key":"e_1_2_24_14_2","first-page":"5","article-title":"Review of atypical antipsychotics and weight gain","volume":"62","author":"Sussman N.","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_24_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00114-2"},{"key":"e_1_2_24_16_2","doi-asserted-by":"publisher","DOI":"10.1124\/jpet.102.035303"},{"key":"e_1_2_24_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-9338(97)89490-4"},{"key":"e_1_2_24_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(00)80086-7"},{"key":"e_1_2_24_19_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.159.1.133"},{"key":"e_1_2_24_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00112-9"},{"key":"e_1_2_24_21_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.4.5.717"},{"key":"e_1_2_24_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0306-4530(02)00113-0"},{"key":"e_1_2_24_23_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.107.s416.4.x"},{"key":"e_1_2_24_24_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.2003.00064.x"},{"key":"e_1_2_24_25_2","unstructured":"GuyW.(ed):ECDEU Assessment Manual for Psychopharmacology: Publication ADM 76\u2013338. Washington DC US Department of Health Education and Welfare 1976."},{"key":"e_1_2_24_26_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.107.s416.5.x"},{"key":"e_1_2_24_27_2","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0447.107.s416.6.x"},{"key":"e_1_2_24_28_2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/biomet\/73.1.13","article-title":"Longitudinal data analysis using generalized linear models","volume":"73","author":"Liang KY","year":"1988","journal-title":"Biometrika"},{"key":"e_1_2_24_29_2","article-title":"Effectiveness of antipsychotic treatment for schizophrenia in the outpatient setting. Six\u2010months results of the European SOHO study involving over 10,000 patients","author":"Haro JM","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"e_1_2_24_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1970.tb02066.x"},{"key":"e_1_2_24_31_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.154.4.457"},{"key":"e_1_2_24_32_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1039-8562.2003.00535.x"},{"key":"e_1_2_24_33_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.158.5.765"},{"key":"e_1_2_24_34_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216030-00007"},{"key":"e_1_2_24_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(02)85018-4"},{"key":"e_1_2_24_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s002130050028"},{"key":"e_1_2_24_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)13306-5"},{"key":"e_1_2_24_38_2","first-page":"101","volume-title":"Atypical neuroleptics in the treatment of schizophrenic patients","author":"Lambert M.","year":"2002"},{"key":"e_1_2_24_39_2","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200216010-00003"},{"key":"e_1_2_24_40_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v63n1206"},{"key":"e_1_2_24_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(01)00109-2"},{"key":"e_1_2_24_42_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1999.tb10842.x"},{"key":"e_1_2_24_43_2","doi-asserted-by":"publisher","DOI":"10.1037\/0021-843X.98.4.367"},{"key":"e_1_2_24_44_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.164.5.630"},{"issue":"4","key":"e_1_2_24_45_2","first-page":"21","article-title":"A 5\u2010year prospective longitudinal study of tardive dyskinesia: factors predicting appearance of new cases","volume":"8","author":"Chouinard G","year":"1988","journal-title":"J Clin Psychopharmacol"},{"key":"e_1_2_24_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1994.tb05825.x"},{"key":"e_1_2_24_47_2","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1176\/ajp.156.4.544","article-title":"Predictors of treatment response from a first episode of schizophrenia or schizoaffective disorder","volume":"156","author":"Robinson DG","year":"1999","journal-title":"Am J Psychiatry"},{"key":"e_1_2_24_48_2","doi-asserted-by":"publisher","DOI":"10.1093\/schbul\/20.2.339"},{"issue":"23","key":"e_1_2_24_49_2","first-page":"13","article-title":"Epidemiology, morbidity, and treatment of overweight and obesity","volume":"62","author":"Aronne LJ.","year":"2001","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"e_1_2_24_50_2","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1097\/01.jcp.0000084037.22282.a3","article-title":"The implications of weight changes with antipsychotic treatment","volume":"23","author":"Sussman N.","year":"2003","journal-title":"J Clin Psychopharmcol"},{"issue":"23","key":"e_1_2_24_51_2","first-page":"23","article-title":"Mechanisms of antipsychotic\u2010induced weight gain","volume":"62","author":"Mcintyre RS","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_24_52_2","doi-asserted-by":"publisher","DOI":"10.1176\/ajp.156.11.1686"},{"key":"e_1_2_24_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0920-9964(02)00431-0"},{"key":"e_1_2_24_54_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0404"},{"key":"e_1_2_24_55_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v62n0204"},{"issue":"23","key":"e_1_2_24_56_2","first-page":"45","article-title":"Genetic dissection of atypical antipsychotic\u2010induced weight gain: novel preliminary data on the pharmacogenetic puzzle","volume":"62","author":"Basile VS","year":"2001","journal-title":"J Clin Psychiatry"},{"key":"e_1_2_24_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-200206000-00003"},{"key":"e_1_2_24_58_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.1.50"},{"key":"e_1_2_24_59_2","doi-asserted-by":"publisher","DOI":"10.1097\/00004714-199710000-00010"},{"key":"e_1_2_24_60_2","doi-asserted-by":"publisher","DOI":"10.1080\/713847170"},{"key":"e_1_2_24_61_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.182.3.199"},{"key":"e_1_2_24_62_2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.3.10.1381"},{"key":"e_1_2_24_63_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0447.1985.tb01268.x"},{"key":"e_1_2_24_64_2","doi-asserted-by":"publisher","DOI":"10.3109\/10401230309085668"}],"container-title":["Acta Psychiatrica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1600-0447.2004.00451.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1600-0447.2004.00451.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,16]],"date-time":"2023-10-16T02:05:17Z","timestamp":1697421917000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1600-0447.2004.00451.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11,10]]},"references-count":63,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2005,3]]}},"alternative-id":["10.1111\/j.1600-0447.2004.00451.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1600-0447.2004.00451.x","archive":["Portico"],"relation":{},"ISSN":["0001-690X","1600-0447"],"issn-type":[{"value":"0001-690X","type":"print"},{"value":"1600-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,11,10]]}}}